drugset / Trial / NCT02139241

The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery

NCT02139241

Completed 114 enrolled Seoul National University Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to assess the effects of ramosetron on corrected QT interval in patients undergoing off pump coronary artery bypass surgery.

Timeline

Start
2013-06
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramosetron Small molecule 0.3 mg Intravenous